Evidence has indicated that EPO attenuates obesity and diabetes in mouse models10, 11, 13 and promotes energy metabolism in adipocytes14, 36 and fat oxidation in muscle37. The gene discussed is EPO; the disease is obesity due to melanocortin 4 receptor deficiency.